Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
2.400
-0.240 (-9.09%)
At close: Aug 25, 2026, 4:00 PM EDT
2.410
+0.010 (0.42%)
After-hours: Aug 25, 2026, 7:30 PM EDT

Aethlon Medical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
----0.570.29
Revenue Growth
----95.21%-55.37%
Gross Profit
----0.570.29
Selling, General & Admin
7.087.299.3412.6412.4710.72
Operating Expenses
7.087.299.3412.6412.4710.72
Operating Income
-7.08-7.29-9.34-12.64-11.9-10.42
Interest Expense
-0.01-0.01-0.01---
Interest & Investment Income
0.160.160.30.450.01-
Other Non Operating Income (Expenses)
---4.33-0.02--
EBT Excluding Unusual Items
-6.94-7.15-13.39-12.21-11.89-10.42
Gain (Loss) on Sale of Assets
-----0.14-
Pretax Income
-6.94-7.15-13.39-12.21-12.03-10.42
Earnings From Continuing Operations
-6.94-7.15-13.39-12.21-12.03-10.42
Minority Interest in Earnings
-----0
Net Income
-6.94-7.15-13.39-12.21-12.03-10.42
Net Income to Common
-6.94-7.15-13.39-12.21-12.03-10.42
Net Income Growth
------
Shares Outstanding (Basic)
000---
Shares Outstanding (Diluted)
000---
Shares Change
497.17%331.78%----
EPS (Basic)
-31.45-53.06-428.87---
EPS (Diluted)
-31.45-53.06-428.87---
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-7.19-7-7.65-10.38-11.45-10.12
Free Cash Flow Per Share
-32.61-51.95-244.92---
Gross Margin
----100.00%100.00%
Operating Margin
-----2072.05%-3542.53%
Profit Margin
-----2094.89%-3540.90%
Free Cash Flow Margin
-----1993.62%-3439.01%
EBITDA
-6.77-6.97-9-12.28-11.66-10.3
D&A For EBITDA
0.310.320.340.360.240.12
EBIT
-7.08-7.29-9.34-12.64-11.9-10.42
Revenue as Reported
----0.570.29
SEC Filings: 10-K · 10-Q